Clinical trial NCT00315133 - References

Type 1 Diabetes Mellitus — Safety and Efficacy Study of Autologous Stem Cell Transplantation for Early Onset Type I Diabetes Mellitus

Citation(s)

•   Burt RK, Oyama Y, Traynor A, Kenyon NS
  Hematopoietic stem cell therapy for type 1 diabetes: induction of tolerance and islet cell neogenesis. Autoimmun Rev. 2002 May;1(3):133-8. Review.
•   Couri CE, Oliveira MC, Stracieri AB, Moraes DA, Pieroni F, Barros GM, Madeira MI, Malmegrim KC, Foss-Freitas MC, Simões BP, Martinez EZ, Foss MC, Burt RK, Voltarelli JC
  C-peptide levels and insulin independence following autologous nonmyeloablative hemat
•   Voltarelli JC, Couri CE, Stracieri AB, Oliveira MC, Moraes DA, Pieroni F, Coutinho M, Malmegrim KC, Foss-Freitas MC, Simões BP, Foss MC, Squiers E, Burt RK
  Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diab

Autologous Hematopoietic Stem Cell Transplantation for Early Onset Type 1 Diabetes Mellitus- a Phase I/II Study

Details for clinical trial NCT00315133